AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29564932 — intervention group
Group type: COMPARATOR
Intervention: U‐100 lispro
Number of subjects: 126
Study 26604159 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4) for 12 hours (loading dose 4g IV, maintenance 1g/hour)
Number of subjects: 204
Study 26604159 — intervention group
Group type: COMPARATOR
Intervention: Magnesium sulfate (MgSO4) for 24 hours (loading dose 4g IV, maintenance 1g/hour)
Number of subjects: 204
Study 25740794 — intervention group
Group type: EXPERIMENTAL
Intervention: valACV 500 mg twice daily for 12 weeks
Number of subjects: 18
Study 25740794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 24371878 — intervention group
Group type: COMPARATOR
Intervention: Silver alloy-coated catheters
Number of subjects: 0
Study 24371878 — intervention group
Group type: COMPARATOR
Intervention: Nitrofurazone-impregnated catheters
Number of subjects: 0
Study 24371878 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard catheters
Number of subjects: 0
Study 20156979 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT)
Number of subjects: 45
Study 20156979 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing retraining (BRT)
Number of subjects: 45
Study 20156979 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study 18619359 — intervention group
Group type: EXPERIMENTAL
Intervention: Bailing capsule and medical gymnastics
Number of subjects: 50
Study 18619359 — intervention group
Group type: COMPARATOR
Intervention: Routine western medicine (Control)
Number of subjects: 50
Study 17235419 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct stenting
Number of subjects: 95
Study 17235419 — intervention group
Group type: COMPARATOR
Intervention: Balloon predilatation followed by stenting
Number of subjects: 95
Study 12568831 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of E2
Number of subjects: 62
Study 12568831 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of E2 + 5 mg of medroxyprogesterone acetate (MPA)
Number of subjects: 62
Study 12568831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 11082818 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (OXC)
Number of subjects: 200000
Study 8854286 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline Lavipharm (200 mg or 300 mg)
Number of subjects: 48
Study 8854286 — intervention group
Group type: COMPARATOR
Intervention: Theodur (200 mg or 300 mg)
Number of subjects: 48
Study 1607899 — intervention group
Group type: EXPERIMENTAL
Intervention: Outdoor air ventilation at 10 cfmpp
Number of subjects: 254
Study 1607899 — intervention group
Group type: EXPERIMENTAL
Intervention: Outdoor air ventilation at 20 cfmpp
Number of subjects: 254
Study 1607899 — intervention group
Group type: EXPERIMENTAL
Intervention: Outdoor air ventilation at 50 cfmpp
Number of subjects: 254
Study 1607899 — intervention group
Group type: EXPERIMENTAL
Intervention: Blinding to the intervention
Number of subjects: 254
Study 1607899 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly non-response
Number of subjects: 254
Study 6092012 — intervention group
Group type: EXPERIMENTAL
Intervention: cefotaxime 3 x 2 g
Number of subjects: 100
Study 6092012 — intervention group
Group type: EXPERIMENTAL
Intervention: lamoxactam 3 x 2 g
Number of subjects: 100
Study 6092012 — intervention group
Group type: EXPERIMENTAL
Intervention: cefmenoxime 3 x 1 g
Number of subjects: 100
Study 6092012 — intervention group
Group type: EXPERIMENTAL
Intervention: mezlocillin 3 x 5 g
Number of subjects: 100
Study 6092012 — intervention group
Group type: EXPERIMENTAL
Intervention: piperacillin 3 x 4 g
Number of subjects: 100
Study 31121926 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Nutritional Supplements (ONS) - 2 packs daily for 8 weeks
Number of subjects: 34
Study 31121926 — intervention group
Group type: COMPARATOR
Intervention: Non-Oral Nutritional Supplements (non-ONS)
Number of subjects: 34
Study 28934067 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaze stability exercises for 10 minutes
Number of subjects: 0
Study 28934067 — intervention group
Group type: COMPARATOR
Intervention: Control group (resting)
Number of subjects: 0
Study 26798037 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensei X™ robotic navigation system (RNS) during pulmonary vein isolation (PVI) procedures
Number of subjects: 80
Study 25200644 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 68
Study 25200644 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 68
Study 21807474 — intervention group
Group type: EXPERIMENTAL
Intervention: Information film presented as a complement to written and verbal information
Number of subjects: 390
Study 21807474 — intervention group
Group type: COMPARATOR
Intervention: Control group (no information film)
Number of subjects: 390
Study 21807474 — intervention group
Group type: EXPERIMENTAL
Intervention: Information film
Number of subjects: 390
Study 20137063 — intervention group
Group type: EXPERIMENTAL
Intervention: Naprapathic manual therapy (spinal manipulation/mobilization, massage, and stretching)
Number of subjects: 409
Study 20137063 — intervention group
Group type: COMPARATOR
Intervention: Advice to stay active and cope with pain (Control Group)
Number of subjects: 409
Study 18045283 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc sulfate
Number of subjects: 150
Study 18045283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 15640478 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (approximately 670 mg/d)
Number of subjects: 354
Study 15640478 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 354
Study 12360174 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous monteplase pretreatment before coronary angioplasty (Group II)
Number of subjects: 154
Study 12360174 — intervention group
Group type: COMPARATOR
Intervention: Direct coronary angioplasty (Group I)
Number of subjects: 154
Study 10807887 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg three times daily
Number of subjects: 14
Study 10807887 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 9010610 — intervention group
Group type: EXPERIMENTAL
Intervention: sustained-release ibuprofen (1600 mg daily)
Number of subjects: 61
Study 9010610 — intervention group
Group type: COMPARATOR
Intervention: sustained-release diclofenac sodium (100 mg daily)
Number of subjects: 61
Study 1621533 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-halftime warm-up and stretching routine (3 minutes)
Number of subjects: 108
Study 1621533 — intervention group
Group type: COMPARATOR
Intervention: No warm-up and stretching intervention (Control)
Number of subjects: 108
Study 3883375 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine solution instillation into the breast parenchyma
Number of subjects: 0
Study 3883375 — intervention group
Group type: COMPARATOR
Intervention: Control solution
Number of subjects: 0
Study 30100576 — intervention group
Group type: EXPERIMENTAL
Intervention: Epworth Sleepiness Scale (ESS) intervention
Number of subjects: 639
Study 30100576 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed MID for the ESS
Number of subjects: 639
Study 28967710 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized counselling intervention
Number of subjects: 30
Study 28967710 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 30
Study 27173169 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based self-management system
Number of subjects: 47
Study 24043484 — intervention group
Group type: EXPERIMENTAL
Intervention: S-cTnI assay
Number of subjects: 222
Study 24043484 — intervention group
Group type: EXPERIMENTAL
Intervention: hs-cTnT assay
Number of subjects: 222
Study 22623888 — intervention group
Group type: EXPERIMENTAL
Intervention: Dejian mind-body intervention (DMBI)
Number of subjects: 75
Study 22623888 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 75
Study 22623888 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 75
Study 20735834 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymostimulin 75 mg s.c. 5x/week
Number of subjects: 135
Study 20735834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 18242365 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentosan polysulfate sodium (PPS) 300 mg/day for 32 weeks
Number of subjects: 128
Study 15986237 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training for 3 months
Number of subjects: 139
Study 12704967 — intervention group
Group type: EXPERIMENTAL
Intervention: Web‐based instructional format
Number of subjects: 33
Study 12704967 — intervention group
Group type: COMPARATOR
Intervention: Slide/audiotape instructional format
Number of subjects: 33
Study 10411795 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene (50 mg days 5 to 9)
Number of subjects: 5
Study 10411795 — intervention group
Group type: COMPARATOR
Intervention: Control cycles
Number of subjects: 5
Study 7756105 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine HCl (3 mg kg‐1)
Number of subjects: 20
Study 7756105 — intervention group
Group type: COMPARATOR
Intervention: Chronic tobacco smoking
Number of subjects: 20
Study 2310250 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefamandole nafate
Number of subjects: 400
Study 2310250 — intervention group
Group type: COMPARATOR
Intervention: Cefonicid
Number of subjects: 400
Study 7014656 — intervention group
Group type: EXPERIMENTAL
Intervention: Propiram fumarate (50 mg)
Number of subjects: 0
Study 7014656 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentazocine (50 mg)
Number of subjects: 0
Study 7014656 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine (60 mg)
Number of subjects: 0
Study 7014656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31204198 — intervention group
Group type: EXPERIMENTAL
Intervention: Single shot of intravenous TXA 10 mg/kg
Number of subjects: 176
Study 31204198 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Control group)
Number of subjects: 176
Study 27989852 — intervention group
Group type: EXPERIMENTAL
Intervention: 30mg morphine
Number of subjects: 39
Study 27989852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 26487746 — intervention group
Group type: EXPERIMENTAL
Intervention: Curved edge catheter (Tiemann type)
Number of subjects: 20
Study 26487746 — intervention group
Group type: COMPARATOR
Intervention: Conventional suction catheter
Number of subjects: 20
Study 23085096 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy with balloon dilation (ESBD)
Number of subjects: 156
Study 23085096 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic sphincterotomy (ES)
Number of subjects: 156
Study 20479767 — intervention group
Group type: EXPERIMENTAL
Intervention: Body-weight-supported treadmill (BWST) training
Number of subjects: 7
Study 20479767 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilt-table standing (TTS) training
Number of subjects: 7
Study 20479767 — intervention group
Group type: EXPERIMENTAL
Intervention: Single session of BWST
Number of subjects: 7
Study 20479767 — intervention group
Group type: EXPERIMENTAL
Intervention: Single session of TTS
Number of subjects: 7
Study 20479767 — intervention group
Group type: EXPERIMENTAL
Intervention: BWST and TTS training
Number of subjects: 7
Study 18723314 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine + Tipifarnib (G+t)
Number of subjects: 244
Study 18723314 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine + Placebo (G+p)
Number of subjects: 244
Study 16702498 — intervention group
Group type: COMPARATOR
Intervention: Tazarotene gel plus placebo capsules
Number of subjects: 189
Study 16702498 — intervention group
Group type: COMPARATOR
Intervention: Minocycline capsules plus vehicle gel
Number of subjects: 189
Study 16702498 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene gel plus minocycline capsules
Number of subjects: 189
Study 15611422 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral alitretinoin 10 mg/d
Number of subjects: 319
Study 15611422 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral alitretinoin 20 mg/d
Number of subjects: 319
Study 15611422 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral alitretinoin 40 mg/d
Number of subjects: 319
Study 15611422 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 319
Study 11697833 — intervention group
Group type: EXPERIMENTAL
Intervention: Early hyperfractionated thoracic radiation therapy (HTRT) concurrently with the first cycle of chemotherapy (Group A)
Number of subjects: 81
Study 11697833 — intervention group
Group type: EXPERIMENTAL
Intervention: Late hyperfractionated thoracic radiation therapy (HTRT) concurrently with the fourth cycle of chemotherapy (Group B)
Number of subjects: 81
Study 11697833 — intervention group
Group type: COMPARATOR
Intervention: Comparison of early vs late HTRT
Number of subjects: 81
Study 9397246 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (5 or 10 mg)
Number of subjects: 123
Study 9397246 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem (180, 240, or 360 mg)
Number of subjects: 123
Study 7978566 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous prochlorperazine (10 mg)
Number of subjects: 45
Study 7978566 — intervention group
Group type: COMPARATOR
Intervention: Rectal prochlorperazine (25 mg)
Number of subjects: 45
Study 7978566 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous prochlorperazine
Number of subjects: 45
Study 7978566 — intervention group
Group type: COMPARATOR
Intervention: Rectal prochlorperazine
Number of subjects: 45
Study 2498820 — intervention group
Group type: EXPERIMENTAL
Intervention: Autoinflation (3 times daily for 2 weeks)
Number of subjects: 41
Study 2498820 — intervention group
Group type: COMPARATOR
Intervention: Observation (control group)
Number of subjects: 41
Study 1041750 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin G
Number of subjects: 84
Study 1041750 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin
Number of subjects: 84
Study 31434782 — intervention group
Group type: EXPERIMENTAL
Intervention: SBRT monotherapy (40 Gy in five fractions given on alternating days)
Number of subjects: 472
Study 31434782 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual high-dose rate boost (HDRB) (20 Gy in two fractions followed by 36 Gy in 12 fractions)
Number of subjects: 472
Study 28158982 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine treatment (50 micrograms daily, titrated according to TSH level)
Number of subjects: 750
Study 28158982 — intervention group
Group type: COMPARATOR
Intervention: Placebo (mock titration)
Number of subjects: 750
Study 28158982 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine treatment
Number of subjects: 750
Study 25959908 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk containing 600 IU Vitamin D/1000cc
Number of subjects: 0
Study 25959908 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk containing 1000 IU Vitamin D/1000cc
Number of subjects: 0
Study 25959908 — intervention group
Group type: COMPARATOR
Intervention: Whole milk (non-fortified)
Number of subjects: 0
Study 22828004 — intervention group
Group type: EXPERIMENTAL
Intervention: Genome-wide association studies (GWAS)
Number of subjects: 0
Study 22828004 — intervention group
Group type: COMPARATOR
Intervention: Harmonized case control definitions
Number of subjects: 0
Study 24800335 — intervention group
Group type: EXPERIMENTAL
Intervention: Clean Intermittent Self Catheterisation (CISC) performed by inserting a Classic Neleton Catheter (No. 16 or 18) twice a day for 1 week, then once a day for another 4 weeks and then once weekly continued for one year.
Number of subjects: 60
Study 24800335 — intervention group
Group type: COMPARATOR
Intervention: Internal Optical Urethrotomy (control group)
Number of subjects: 60
Study 24800335 — intervention group
Group type: EXPERIMENTAL
Intervention: Clean Intermittent Self Catheterisation (CISC)
Number of subjects: 60
Study 24800335 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CISC)
Number of subjects: 60
Study 19802806 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low-protein diet (VLpD)
Number of subjects: 32
Study 19802806 — intervention group
Group type: COMPARATOR
Intervention: Low-protein diet (LpD)
Number of subjects: 32
Study 17355489 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 100 mg per day
Number of subjects: 756
Study 17355489 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 756
Study 15254052 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan 100 mg/m² weekly for 4 weeks followed by a 2-week rest (weekly arm)
Number of subjects: 103
Study 15254052 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan 240 mg/m² every 3 weeks (every‐3‐weeks arm)
Number of subjects: 103
Study 11536090 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone-patellar tendon-bone with interference screw fixation (Group A)
Number of subjects: 55
Study 11536090 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone-patellar tendon-bone with transcondylar screw fixation (Group B)
Number of subjects: 55
Study 9564110 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum
Number of subjects: 189
Study 9564110 — intervention group
Group type: COMPARATOR
Intervention: Plasmanate
Number of subjects: 189
Study 7812416 — intervention group
Group type: EXPERIMENTAL
Intervention: Total body water estimation of body fat
Number of subjects: 35
Study 7812416 — intervention group
Group type: COMPARATOR
Intervention: Underwater weight estimation of body fat
Number of subjects: 35
Study 3378905 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-week training program on personal health skills
Number of subjects: 88
Study 28960663 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose transdermal nicotine (90 mg/day)
Number of subjects: 40
Study 28944715 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance training
Number of subjects: 26
Study 28944715 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular activity schedule)
Number of subjects: 26
Study 25913046 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypotonic solution (Na 30 mEq/L NaCl or 0.18%)
Number of subjects: 50
Study 25913046 — intervention group
Group type: COMPARATOR
Intervention: Isotonic solution (Na 150 mEq/L or 0.9% NaCl)
Number of subjects: 50
Study 25913046 — intervention group
Group type: EXPERIMENTAL
Intervention: Both isotonic and hypotonic solutions
Number of subjects: 50
Study 23937999 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol (acetaminophen)
Number of subjects: 0
Study 23937999 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20653455 — intervention group
Group type: EXPERIMENTAL
Intervention: Both medications at bedtime (valsartan 160 mg/day and amlodipine 5 mg/day)
Number of subjects: 203
Study 20653455 — intervention group
Group type: COMPARATOR
Intervention: Both medications on awakening (valsartan 160 mg/day and amlodipine 5 mg/day)
Number of subjects: 203
Study 20653455 — intervention group
Group type: COMPARATOR
Intervention: Valsartan on awakening and amlodipine at bedtime
Number of subjects: 203
Study 20653455 — intervention group
Group type: COMPARATOR
Intervention: Valsartan at bedtime and amlodipine on awakening
Number of subjects: 203
Study 18422825 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention practices promoting alcohol screening and brief counseling
Number of subjects: 21
Study 18422825 — intervention group
Group type: COMPARATOR
Intervention: Control practices
Number of subjects: 21
Study 16997056 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin/citrate (4 mg/mL)
Number of subjects: 62
Study 16997056 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline/EDTA
Number of subjects: 62
Study 16997056 — intervention group
Group type: COMPARATOR
Intervention: Heparin (control)
Number of subjects: 62
Study 12677265 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic gastric banding
Number of subjects: 40
Study 12677265 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss greater than 1.7% per week
Number of subjects: 40
Study 12677265 — intervention group
Group type: COMPARATOR
Intervention: Normal-weight volunteers (control group)
Number of subjects: 40
Study 10872960 — intervention group
Group type: EXPERIMENTAL
Intervention: Curved bristle toothbrush
Number of subjects: 100
Study 10872960 — intervention group
Group type: COMPARATOR
Intervention: Conventional straight bristle toothbrush
Number of subjects: 100
Study 9541997 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk from Russian women
Number of subjects: 0
Study 9541997 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk from Vietnamese women
Number of subjects: 0
Study 9541997 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk from both Vietnamese and Russian women
Number of subjects: 0
Study 9541997 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of food components and toxic compounds
Number of subjects: 0
Study 8173923 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine infusion at 3 micrograms kg‐1 min‐1 for 48 hours after surgery
Number of subjects: 23
Study 8173923 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving 3 litres 5% dextrose and bolus of intravenous frusemide 1 mg kg‐1
Number of subjects: 23
Study 8173923 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (dopamine and control)
Number of subjects: 23
Study 8173923 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine infusion
Number of subjects: 23
Study 2852111 — intervention group
Group type: EXPERIMENTAL
Intervention: Calciparine (15,000 IU day‐1)
Number of subjects: 80
Study 2852111 — intervention group
Group type: COMPARATOR
Intervention: Fragmin (5000 anti‐Xa U/d)
Number of subjects: 80
Study 29802770 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral, preconversation, communication-priming intervention (Jumpstart-Tips)
Number of subjects: 537
Study 29802770 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 537
Study 28833428 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback containing normative comparisons
Number of subjects: 0
Study 28833428 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback reports including lists of clinical presentations
Number of subjects: 0